Tradestie Institutional Equity Comparison Engine

NDRA vs NEO โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-17 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

NEO Overall Edge

NEO Captures Institutional Edge (3โ€“1 Pillars ยท 5โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to NeoGenomics, Inc. (NEO) driven by superior Valuation, Momentum & Technical, Options & Structure while NDRA counters with relative strength in Growth & Margin. Fundamentally, NDRA trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus NEO at N/M Forward P/E and -5.5% operating margin (+11.4% YoY). In options structure, NDRA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against NEO sits in CONSOLIDATION (14th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner NEO
NDRA N/M vs NEO N/M Fwd P/E
Growth & Margin Winner NDRA
Op Margin 0.0% vs -5.5% ยท YoY +0.0% vs +11.4%
Momentum & Technical Winner NEO
1Y -32.7% vs +49.9% ยท 52W Pos 37% vs 64%
Options & Structure Winner NEO
UNCLASSIFIED (N/A IV) vs CONSOLIDATION (14th %ile IV)
NDRA NASDAQ
ENDRA Life Sciences Inc. Common Stock
Electromedical & Electrotherapeutic Apparatus
$4.42
+0.23% 1D
Market Cap $6.6M
1M Return -6.75%
1Y Return -32.72%
Forward P/E N/M
Unified AI Score
44.7 / 100 HOLD
Tech 35.0 Fund 46.0 Flow 50.0 Mom 60.0
NEO NASDAQ
NeoGenomics, Inc.
Services-Testing Laboratories
$15.49
+0.55% 1D
Market Cap $2.1B
1M Return -5.63%
1Y Return +49.85%
Forward P/E N/M
Unified AI Score
35.6 / 100 SELL
Tech 23.0 Fund 44.0 Flow 58.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: NDRA -32.72% NEO +49.85% Spread: +83.06 pp (NEO Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period NDRA Revenue NEO Revenue NDRA Op. Margin NEO Op. Margin Margin Edge
FY2018 $0M $280M -146080.5% 3.6% NEO
FY2019 N/A $410M N/A 3.2% NEO
FY2020 N/A $440M N/A -3.1% NEO
FY2021 N/A $480M N/A -24.5% NEO
FY2022 N/A $510M N/A -30.9% NEO
FY2023 N/A $590M N/A -18.2% NEO
FY2024 N/A $660M N/A -13.9% NEO
FY2025 N/A $730M N/A -15.9% NEO

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: NDRA (3) vs NEO (5)
Institutional Metric NDRA NEO Criterion Row Winner
Market Capitalization Scale $6.6M $2.1B Larger Scale NEO
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% +11.4% Higher Growth NEO
Operating Margin (TTM) Profitability 0.0% -5.5% Higher Margin NDRA
Net Profit Margin Profitability 0.0% -4.1% Higher Margin NDRA
Return on Equity (ROE) Capital Efficiency -152.0% -3.9% Higher ROE NEO
52-Week Range Position Momentum 37% ($3โ€“$7) 64% ($7โ€“$20) Stronger Trend NEO
Beta / 30D Volatility Risk Regime 0.71ฮฒ ยท 48% Vol 1.23ฮฒ ยท 47% Vol Lower Realized Risk NEO
Unified Institutional Score Composite Signal 44.7 / 100 (HOLD) 35.6 / 100 (SELL) Higher Composite NDRA

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full NDRA vs NEO Buy Guide
NDRA UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live NDRA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
NEO CONSOLIDATION
69d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 14th %ile
IV Regime Compressed (<25th %ile)
Live NEO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither NDRA nor NEO registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.